228 related articles for article (PubMed ID: 6644585)
1. Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats.
Tsuji A; Yoshikawa T; Nishide K; Minami H; Kimura M; Nakashima E; Terasaki T; Miyamoto E; Nightingale CH; Yamana T
J Pharm Sci; 1983 Nov; 72(11):1239-52. PubMed ID: 6644585
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
Tsuji A; Nishide K; Minami H; Nakashima E; Terasaki T; Yamana T
Drug Metab Dispos; 1985; 13(6):729-39. PubMed ID: 2867880
[TBL] [Abstract][Full Text] [Related]
3. Effect of extracellular water volume on the distribution kinetics of beta-lactam antibiotics as a function of age.
Tsuji A; Terasaki T; Imaeda N; Nishide K; Nakashima E
J Pharmacobiodyn; 1985 Mar; 8(3):167-74. PubMed ID: 4009409
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal transport of beta-lactam antibiotics: effects of plasma protein binding and the interspecies relationship.
Deguchi Y; Nakashima E; Ishikawa F; Sato H; Tamai I; Matsushita R; Tofuku Y; Ichimura F; Tsuji A
J Pharm Sci; 1988 Jul; 77(7):559-64. PubMed ID: 3171941
[TBL] [Abstract][Full Text] [Related]
5. A Whole-Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat.
Bouchene S; Marchand S; Couet W; Friberg LE; Gobin P; Lamarche I; Grégoire N; Björkman S; Karlsson MO
Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):407-422. PubMed ID: 29665289
[TBL] [Abstract][Full Text] [Related]
6. Age-related change in tissue-to-plasma partition coefficient of cefazolin for noneliminating organs in the rat.
Tsuji A; Terasaki T; Imaeda N; Nishide K; Tamai I
J Pharm Sci; 1989 Jul; 78(7):535-40. PubMed ID: 2778652
[TBL] [Abstract][Full Text] [Related]
7. Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.
Harashima H; Sawada Y; Sugiyama Y; Iga T; Hanano M
J Pharmacokinet Biopharm; 1985 Aug; 13(4):425-40. PubMed ID: 4087170
[TBL] [Abstract][Full Text] [Related]
8. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
[TBL] [Abstract][Full Text] [Related]
9. Moment analysis of drug disposition in kidney. V: In vivo transepithelial transport of p-aminohippurate in rat kidney.
Hori R; He YL; Saito Y; Kamiya A; Tanigawara Y
J Pharmacokinet Biopharm; 1991 Feb; 19(1):51-70. PubMed ID: 2023109
[TBL] [Abstract][Full Text] [Related]
10. Effect of diabetes on disposition and renal handling of cefazolin in rats.
Nadai M; Yoshizumi H; Kuzuya T; Hasegawa T; Johno I; Kitazawa S
Drug Metab Dispos; 1990; 18(5):565-70. PubMed ID: 1981703
[TBL] [Abstract][Full Text] [Related]
11. Physiologically based pharmacokinetic model for the renal clearance of phenolsulfonphthalein and the interaction with probenecid and salicyluric acid in the dog.
Russel FG; Wouterse AC; van Ginneken CA
J Pharmacokinet Biopharm; 1987 Aug; 15(4):349-68. PubMed ID: 3681664
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Sch 34343 in rats and dogs.
Lin C; Loebenberg D; Chung M; Oden E; Veals J; Kim H; Lim J; Korduba C; D'Souza R; Moss E
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():219-26. PubMed ID: 4030549
[TBL] [Abstract][Full Text] [Related]
13. Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids.
Okezaki E; Terasaki T; Nakamura M; Nagata O; Kato H; Tsuji A
Drug Metab Dispos; 1988; 16(6):865-74. PubMed ID: 2907467
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent pharmacokinetics of probenecid in the rat.
Emanuelsson BM; Paalzow LK
Biopharm Drug Dispos; 1988; 9(1):59-70. PubMed ID: 3342285
[TBL] [Abstract][Full Text] [Related]
16. Prediction of glycyrrhizin disposition in rat and man with liver failure by a physiologically based pharmacokinetic model.
Ishida S; Sakiya Y; Ichikawa T; Taira Z; Awazu S
J Pharmacobiodyn; 1990 Feb; 13(2):142-57. PubMed ID: 2384851
[TBL] [Abstract][Full Text] [Related]
17. Non-linear elimination and protein binding of probenecid.
Emanuelsson BM; Beermann B; Paalzow LK
Eur J Clin Pharmacol; 1987; 32(4):395-401. PubMed ID: 3609117
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic model for the renal clearance of iodopyracet and the interaction with probenecid in the dog.
Russel FG; Wouterse AC; Van Ginneken CA
Biopharm Drug Dispos; 1989; 10(2):137-52. PubMed ID: 2706315
[TBL] [Abstract][Full Text] [Related]
19. In vivo evidence for carrier-mediated uptake of beta-lactam antibiotics through organic anion transport systems in rat kidney and liver.
Tsuji A; Terasaki T; Tamai I; Takeda K
J Pharmacol Exp Ther; 1990 Apr; 253(1):315-20. PubMed ID: 2329514
[TBL] [Abstract][Full Text] [Related]
20. Physiologically based pharmacokinetics of drug-drug interaction: a study of tolbutamide-sulfonamide interaction in rats.
Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
J Pharmacokinet Biopharm; 1982 Jun; 10(3):297-316. PubMed ID: 7175701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
